XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding XBiotech Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 53 | 48 | −5 |
| Shares | 3.42M | 2.94M | −480.4K (−14.1%) |
| Value | $10.1M | $7.81M | −$2.34M (−23.0%) |
New holders (4)
Institutions that held XBiotech Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 26,156 | $69.0K | 0.00% |
| SRS Capital Advisors, Inc. | 22 | $58 | 0.00% |
| Optiver Holding B.V. | 8 | $21 | 0.00% |
| Sunbelt Securities, Inc. | 2 | $5 | 0.00% |
Sold out (9)
Institutions that held XBiotech Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 47,885 | $142.2K |
| Susquehanna International Group, LLP | 39,381 | $117.0K |
| Jain Global LLC | 17,629 | $52.4K |
| HSBC Holdings PLC | 16,921 | $48.7K |
| Tower Research Capital LLC (TRC) | 9,332 | $27.7K |
| Russell Investments Group, Ltd. | 1,425 | $4.23K |
| Raymond James Financial Inc | 358 | $1.06K |
| Wells Fargo & Company | 149 | $443 |
| Clearstead Advisors, LLC | 17 | $51 |